SEC Filing Summary: E.W. Scripps Co. (SSP)
Business Context and Reporting Period
This Form 8-K Current Report, dated November 25, 2025, discloses that The E.W. Scripps Company (the "Company") has adopted a poison pill defense mechanism. The Board of Directors declared a dividend of one right for each outstanding Class A Common Share and Common Voting Share. The filing details the entry into a Material Definitive Agreement (Rights Agreement) with Computershare Trust Company, N.A., as the rights agent.
Key Financial Metrics
This filing is a current report regarding corporate governance and capital structure defense; it does not contain financial performance data such as revenue, profit, cash flow, or debt levels.
- Exercise Price: $2.19 per share (subject to adjustment).
- Redemption Price: $0.001 per Right.
- Record Date: December 8, 2025.
- Expiration Date: November 26, 2026, or earlier upon redemption or failure to obtain stockholder approval.
Material Changes and Terms
The primary material change is the implementation of a stockholder rights plan designed to deter unsolicited takeover attempts. Key terms include:
- Trigger Threshold: The plan is triggered if a person or group acquires beneficial ownership of 10% or more of the outstanding shares (an "Acquiring Person").
- Flip-In Provision: Upon triggering, rights holders (excluding the Acquiring Person) may purchase shares with a fair market value equal to approximately two times the Exercise Price.
- Flip-Over Provision: If the Company is acquired after a trigger event, rights holders may purchase shares of the acquiring entity with a fair market value equal to approximately two times the Exercise Price.
- Exchange Option: The Board may exchange rights for one share of the Company per right prior to an Acquiring Person reaching 50% ownership.
- Redemption: The Board may redeem the rights at $0.001 per right at any time prior to a trigger event.
Outlook, Risks, and Management Commentary
The filing indicates the Board's intent to protect stockholder interests against coercive takeover tactics. The Rights Agreement allows the Board to amend terms while the rights are redeemable without stockholder approval. After the rights become non-redeemable, amendments cannot materially adversely affect holder interests without approval. The filing references a press release issued on November 26, 2025, regarding the adoption of the plan.
Investor Verification Checklist
- Verify the exact number of outstanding Class A Common Shares and Common Voting Shares as of the Record Date (December 8, 2025) to calculate total rights issued.
- Review the full text of the Rights Agreement (Exhibit 4.1) for specific definitions of "Acquiring Person" and exceptions for exempt persons.
- Monitor for any public announcements of tender offers or acquisitions exceeding the 10% threshold that would trigger the plan.
- Confirm whether the Board intends to seek stockholder approval at the 2026 annual meeting, as failure to do so would cause the rights to expire.
- Check subsequent filings for any redemption of the rights at the $0.001 price point.